Physician profile
Alan N Berman
NPI 1538146352
$12,245.41
in general payments reported to CMS, 2019-2025
23 companies · $2,230 in 2025
The $2,230 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,412 · 2020: $75.03 · 2021: $2,978 · 2022: $2,384 · 2023: $1,263 · 2024: $1,903 · 2025: $2,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,354 · Food and Beverage: $2,002 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,354.41 |
| Food and Beverage | $2,002.19 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $9,791.33 | 2019-2025 | |
| Smith+Nephew, INC. | $411.24 | 2019-2025 | Grafix, Oasis, Stravix |
| Organogenesis INC. | $339.21 | 2019-2025 | Puraply Wound Matrix |
| Misonix INC | $227.73 | 2019-2021 | |
| Bioventus LLC | $219.43 | 2022-2023 | Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $189.81 | 2019 | |
| Depuy Synthes Sales INC. | $147.37 | 2021-2025 | Monovisc |
| Lifenet Health | $129.68 | 2024 | Theragenesis Wound Matrix |
| Averitas Pharma INC. | $111.11 | 2023 | Qutenza |
| Molnlycke Health Care US, LLC | $97.32 | 2021 | |
| Djo, LLC | $84.53 | 2019-2025 | Cmf |
| Gramercy Extremity Orthopedics LLC | $76.46 | 2021 | |
| Hydrofera LLC | $74.49 | 2022-2024 | Hydrofera Blue |
| Aroa Biosurgery Incorporated | $56.21 | 2023 | |
| Paratek Pharmaceuticals, INC. | $53.31 | 2024 | Nuzyra |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $47.65 | 2022-2023 | Xiaflex |
| Reprise Biomedical, INC. | $47.13 | 2024-2025 | Miro3d |
| Terumo Bct, INC. | $38.99 | 2020 | |
| Kerecis Limited | $33.33 | 2019 | |
| Endo USA, INC. | $21.64 | 2024 | Xiaflex |
| Next Science LLC | $17.94 | 2023 | Xperience, Blastx, Surgx |
| Pfizer INC. | $15.14 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.